Rls Radiopharmacies company information, Employees & Contact Information

ReAlta Life Sciences Publishes Data Demonstrating RLS-0071 (pegtarazimod) Reduces Brain Inflammation in Preclinical Hypoxic Ischemic Encephalopathy Model BioSpace

Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform GlobeNewswire

RADIOPHARMACY NETWORK RLS ANNOUNCES EXECUTIVE APPOINTMENTS IN SALES AND HUMAN RESOURCES PR Newswire

RLS Expands by Offering Radiopharmaceutical Contract Development and Manufacturing (rCDMO) Services Business Wire

Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction Nature

Rubedo Life Sciences Announces First Patient Dosed with Lead Drug Candidate RLS-1496, the First GPX4 Modulator Targeting Pathologic Senescent Cells To Enter Phase 1 Clinical Trial BioSpace

Bio-clogging mitigation in vertical subsurface flow constructed wetlands using rhamnolipids-citric acid compound ScienceDirect.com

Telix expands US radiopharma footprint with $250M RLS buy BioWorld MedTech

RLS AND SOFIE ENTER STRATEGIC PARTNERSHIP FOR DISTRIBUTION OF NUCLEAR MEDICINE DOSES FOR PATIENTS PR Newswire

Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board BioSpace

RLS Radiopharmacies Partners with Eckert & Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals Business Wire

13 anti-aging biotech companies leading longevity in 2025 Labiotech.eu

Transcriptome-wide association study for restless legs syndrome identifies new susceptibility genes Nature

Effect of hydrophobic fatty acid groups on emulsifying features of rhamnolipids: Experimental and theoretical studies ScienceDirect.com

Private Group RLS (USA) Inc. Acquires GE Healthcare’s U.S. Radiopharmacy Network Business Wire

RLS Awarded Radiopharmaceutical Products (Distributor) Agreement with Premier, Inc. PR Newswire

Insights into rhamnolipid-based soil remediation technologies by safe microorganisms: A critical review ScienceDirect.com

AtomVie Global Radiopharma Collaborates with RLS & UPPI to Strengthen its Existing U.S. Radiotherapeutic Distribution Network PR Newswire

RLS AND EVERGREEN THERAGNOSTICS LAUNCH PARTNERSHIP FOR SALE AND DISTRIBUTION OF NEUROENDOCRINE TUMOR DIAGNOSTIC OCTEVY™ (KIT FOR PREPARATION OF GA 68 DOTATOC INJECTION), PENDING FDA APPROVAL PR Newswire

SpectronRx and RLS Team Up to Give the Radiopharmaceutical Pipeline and Supply Chain a Much-Needed Boost PR Newswire

Antimicrobial activity, foaming properties, and interacting mechanism of rhamnolipids in presence of silk fibroin through spectroscopy, molecular docking, and microbiological experiments ScienceDirect.com

DWNN-RLS: regularized least squares method for predicting circRNA-disease associations BMC Bioinformatics

Australia's Telix Pharma buys RLS (USA) for $230 M to build next gen radiometal production network BioSpectrum Asia

An environmentally stable supramolecular biosolvent: Characterization and study of its potential for the elimination of polar toxic substances in water ScienceDirect.com

Rhamnolipid the Glycolipid Biosurfactant: Emerging trends and promising strategies in the field of biotechnology and biomedicine Microbial Cell Factories

Rhamnolipid CMC prediction ScienceDirect.com

Large genome-wide association study identifies three novel risk variants for restless legs syndrome Nature

Screening and Identification of Novel DNA Aptamer for Targeted Delivery to Injured Podocytes in Glomerular Diseases Wiley

Application of statistical modeling for the production of highly pure rhamnolipids using magnetic biocatalysts: Evaluating its efficiency as a bioremediation agent ScienceDirect.com

Complex Learning in Bio-plausible Memristive Networks Nature

NOCTRIX HEALTH SECURES $40 MILLION SERIES C FINANCING TO COMMERCIALIZE NOVEL DEVICE TREATMENT FOR RESTLESS LEGS SYNDROME (RLS) BioSpace

What’s the Connection Between IBS and Restless Leg Syndrome? Everyday Health

Antibiotic Resistance Thwarted with Biosurfactant Genetic Engineering and Biotechnology News

Suspected Agomelatine-induced restless legs syndrome: a case report BMC Psychiatry

Efficient isolation of rhamnolipids from fermentation broth via an advanced acid-induced precipitation process with heat treatment ScienceDirect.com

Role of surfactant in affecting photo-fermentative bio-hydrogen production performance from corncob ScienceDirect.com

Chemical Induction of Aminoglycoside Uptake Overcomes Antibiotic Tolerance and Resistance in Staphylococcus aureus ScienceDirect.com

Noctrix Health announces publication of landmark results from randomized clinical trial and long-term extension study of its revolutionary Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS) in Sleep BioSpace

Frank C. Urbancic, Jr. 2001-2009.state.gov

Restless abdomen: a spectrum or a phenotype variant of restless legs syndrome? BMC Neurology

Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy BioSpace

Nanoemulsions of synthetic rhamnolipids act as plant resistance inducers without damaging plant tissues or affecting soil microbiota Frontiers

Karen B. Stewart 2001-2009.state.gov

Musculoskeletal pain is associated with restless legs syndrome in young adults BMC Musculoskeletal Disorders

Six Startups Changing The Way We Age BioSpace

Biosurfactant production from marine hydrocarbon-degrading consortia and pure bacterial strains using crude oil as carbon source Frontiers

medi USA Release: Restiffic Restless Leg Foot Wrap Available In Pharmacies BioSpace

Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery Journal of Nanobiotechnology

Restless legs: Mutation in fly version of a human RLS gene disturbs sleep Emory University

medi USA Release: Restiffic Restless Leg Foot Wrap Available In United Kingdom BioSpace

Reliance Life Sciences Gets CDSCO Panel Nod for Phase I/III Trial of Biosimilar Nivolumab Medical Dialogues

Reliance Life Sciences poised to make a big splash Business Today